# Parker-Hannifin Corp (PH) – Financial Analysis

**Date:** August 15, 2025  
**Period Analyzed:** Fiscal Year 2025 (ended June 30, 2025)

---

## Executive Summary

**BLUF: Parker-Hannifin demonstrates exceptional financial performance with record margins (26.1% adjusted segment operating margin), strong cash generation ($3.8B operating cash flow, 19% of sales), and disciplined capital allocation ($1.6B share repurchases). Despite flat revenue growth (1% organic), the company achieved 24% EPS growth through margin expansion and operational excellence. Balance sheet remains healthy with manageable leverage (debt-to-equity 69.3%) and improving working capital position. FY26 guidance projects continued margin expansion and 6% adjusted EPS growth. BUY - Strong execution in industrial recovery environment with premium valuation justified by exceptional margin performance.**

---

## Revenue Analysis

### Revenue Trends

| Metric | FY25 (TTM) | FY24 | FY23 | FY22 | Change (YoY) |
|--------|------------|------|------|------|--------------|
| Total Revenue | $19.85B | $19.93B | $19.07B | $15.86B | (0.4%) |
| Organic Growth | +1.0% | +1.3% | +13.6% | +10.4% | -30 bps |

### Revenue Performance Highlights

**Full Year FY25:**
- Revenue essentially flat at $19.85B vs $19.93B prior year (down 0.4% reported)
- Organic growth of +1.0% demonstrating resilience despite industrial headwinds
- Currency impact: (0.2%), Divestitures: (1.5%)

**Segment Breakdown:**
- **Diversified Industrial:** $13.67B (68.9% of total), down 5.5% reported, (3.0%) organic
- **Aerospace Systems:** $6.19B (31.1% of total), up 13.0% reported, +12.6% organic

**Q4 FY25 Performance:**
- Record Q4 sales of $5.24B, up 1.1% reported, +2.1% organic
- Strongest organic growth quarter of the fiscal year
- Aerospace: +9.7% reported, +8.6% organic
- Industrial North America: (6.9%) reported, (1.4%) organic (improving sequentially)
- Industrial International: +4.3% reported, +0.6% organic (turned positive)

### Revenue Quality Assessment

**Strengths:**
- Aerospace segment showing consistent double-digit organic growth
- Portfolio transformation increasing longer-cycle/secular revenue mix
- 2/3 of portfolio now longer-cycle and aftermarket (reduces cyclicality)
- Diversified geographic exposure

**Challenges:**
- Industrial segment revenue decline (3.0% organic) due to:
  - Transportation market weakness (mid-single digit decline expected in FY26)
  - Off-highway softness (ag market past trough but recovery delayed)
  - Industrial capital spending delays

---

## Profitability Analysis

### Margin Performance

| Metric | FY25 | FY24 | Change | FY23 |
|--------|------|------|--------|------|
| Gross Margin | 36.9% | 35.8% | +110 bps | 33.7% |
| Operating Margin (GAAP) | 20.5% | 19.1% | +140 bps | 16.1% |
| Operating Margin (Adj) | 22.4% | 21.3% | +110 bps | 21.8% |
| EBITDA Margin | 27.3% | 25.2% | +210 bps | 21.4% |
| EBITDA Margin (Adj) | 26.4% | 25.6% | +80 bps | 21.7% |
| Net Margin | 17.8% | 14.3% | +350 bps | 10.9% |
| Net Margin (Adj) | 17.9% | 16.6% | +130 bps | 11.2% |

### Segment Operating Margins

| Segment | FY25 (Adj) | FY24 (Adj) | Change | FY25 (GAAP) |
|---------|------------|------------|--------|-------------|
| Diversified Industrial | 25.1% | 24.2% | +90 bps | 22.8% |
| - North America | 25.5% | 24.6% | +90 bps | 23.2% |
| - International | 24.5% | 23.6% | +90 bps | 22.2% |
| Aerospace Systems | 28.5% | 26.6% | +190 bps | 23.3% |
| **Total Parker** | **26.1%** | **24.9%** | **+120 bps** | **23.0%** |

### Margin Expansion Drivers

**Cost Management Excellence:**
- SG&A as % of sales: 16.4% (FY25) vs 16.6% (FY24), down 20 bps
- Absolute cost base decreased despite inflation pressures
- The Win Strategy™ operational excellence driving continuous improvement
- $50M in restructuring charges, additional $70M expected in FY26

**Pricing Power:**
- Strong pricing discipline across 85 divisions
- Managed tariff impacts without EPS dilution
- Gross margin expansion of 110 bps demonstrates pricing effectiveness

**Mix Benefits:**
- Aerospace mix shift (higher margin segment growing faster)
- Q4 favorable mix in Engineered Materials and Filtration groups
- Aftermarket vs OEM mix improving

**Operational Leverage:**
- Despite negative industrial organic growth, expanded margins through cycle
- Demonstrates structural margin improvement, not just cyclical leverage

---

## Earnings Analysis

### Earnings Per Share

| Metric | FY25 | FY24 | Change | FY23 |
|--------|------|------|--------|------|
| Diluted EPS (GAAP) | $27.12 | $21.84 | +24.2% | $16.04 |
| Diluted EPS (Adj) | $27.33 | $25.44 | +7.4% | $20.04 |
| Basic EPS | $27.52 | $22.13 | +24.4% | $16.23 |

### EPS Growth Components (Q4 YoY)

| Component | Contribution | Notes |
|-----------|--------------|-------|
| Segment Operating Income | +$0.56 | 60% of improvement from operating execution |
| Income Tax Benefit | +$0.47 | Discrete tax items resolved |
| Interest Expense | +$0.12 | Debt paydown throughout year |
| Share Count Reduction | +$0.09 | $1.6B share repurchases |
| Corporate & Other | ($0.32) | Pension expense, FX volatility |

### Earnings Quality

**Strong Fundamentals:**
- 60% of EPS improvement from operating execution (not one-time items)
- Consistent earnings growth trajectory
- High-quality earnings (strong cash conversion)

**One-Time Items (FY25):**
- Gain on divestitures: $252M ($1.94 per share)
- Gain on sale of buildings: $24M ($0.18 per share)
- Discrete tax benefits: $215M ($1.65 per share)
- Business realignment charges: $56M ($0.43 per share)
- Integration costs: $22M ($0.17 per share)

---

## Balance Sheet Analysis

### Financial Position

| Metric | 6/30/2025 | 6/30/2024 | Change | Assessment |
|--------|-----------|-----------|--------|------------|
| Total Assets | $29.49B | $29.30B | +0.6% | Stable |
| Cash & Equivalents | $467M | $422M | +10.7% | Low but adequate |
| Total Debt | $9.29B | $10.56B | (12.0%) | Improved |
| Net Debt | $8.82B | $10.14B | (13.0%) | Improved |
| Total Equity | $13.69B | $12.08B | +13.3% | Strong growth |
| Working Capital | $1.13B | ($514M) | Improved | Positive trend |

### Leverage Metrics

| Metric | 6/30/2025 | 6/30/2024 | Target | Status |
|--------|-----------|-----------|--------|--------|
| Debt/Equity | 69.3% | 87.4% | - | Improving |
| Net Debt/Adj EBITDA | 1.69x | 1.99x | ~2.0x | Below target |
| Current Ratio | 1.19 | 0.93 | >1.0 | Improved |
| Interest Coverage | 11.0x | 8.1x | - | Excellent |

### Balance Sheet Health Assessment

**Strengths:**
- Net debt-to-adjusted EBITDA of 1.69x (below target of 2.0x)
- Working capital improved from negative ($514M) to positive $1.13B
- Strong equity growth (+13.3%) driven by retained earnings
- Debt reduction of $1.27B (12.0%) through cash flow generation

**Considerations:**
- Low cash position ($467M) but strong cash generation supports operations
- Significant goodwill/intangibles ($18.07B) but consistent with acquisition strategy
- Net tangible assets negative ($4.39B) but normal for industrial companies with acquisition history

---

## Cash Flow Analysis

### Cash Flow Performance

| Metric | FY25 | FY24 | Change | % of Sales |
|--------|------|------|--------|------------|
| Operating Cash Flow | $3.78B | $3.38B | +11.8% | 19.0% |
| Free Cash Flow | $3.34B | $2.98B | +12.1% | 16.8% |
| Capital Expenditures | $435M | $400M | +8.8% | 2.2% |
| Adjusted FCF Conversion | 109% | - | - | - |

### Cash Flow Quality

**Operating Cash Flow:**
- Record $3.78B operating cash flow (+12% growth)
- 19.0% of sales (up from 17.0% in FY24)
- Strong conversion: 107% of net income (GAAP)
- After adjusting for non-recurring items: 109% conversion

**Free Cash Flow:**
- Record $3.34B free cash flow (+12% growth)
- 16.8% of sales (up from 15.0% in FY24)
- Consistent double-digit growth trajectory
- Strong cash generation despite flat revenue

**Working Capital:**
- Change in working capital: ($305M) in FY25 vs ($545M) in FY24
- Receivables: Small increase ($6M) - well managed
- Inventory: Increase ($94M) - supporting growth expectations
- Payables: Increase ($101M) - efficient supplier management

### Capital Allocation

| Use of Cash | FY25 | FY24 | Priority |
|-------------|------|------|----------|
| Share Repurchases | $1.76B | $332M | High |
| Dividends | $861M | $782M | High |
| Debt Repayment | $1.35B | $2.00B | High |
| Capital Expenditures | $435M | $400M | Medium |
| Acquisitions | $0 | - | Medium |
| **Total** | **$4.41B** | **$3.51B** | - |

**Capital Allocation Strategy:**
- **Balanced approach:** Dividends, share repurchases, debt reduction, growth investments
- **Share repurchases:** Aggressive $1.76B (40% of cash generated)
- **Dividend growth:** 10% increase, 24.7% payout ratio (sustainable)
- **Debt reduction:** Continued deleveraging with $1.35B net debt paydown
- **Growth investments:** CapEx at 2.2% of sales (increasing to 2.5% in FY26)

---

## Key Financial Metrics Summary

### Profitability Metrics

| Metric | FY25 | FY24 | Industry Context |
|--------|------|------|------------------|
| ROE | 27.4% | 23.5% | Excellent |
| ROA | 9.0% | 9.7% | Strong |
| ROIC | ~15-16% (est) | ~13-14% | Strong |
| Gross Margin | 36.9% | 35.8% | Above average |
| Operating Margin | 20.5% | 19.1% | Industry leading |
| Net Margin | 17.8% | 14.3% | Excellent |

### Efficiency Metrics

| Metric | FY25 | FY24 | Trend |
|--------|------|------|-------|
| Asset Turnover | 0.67x | 0.68x | Stable |
| Inventory Days | ~83 days | ~79 days | Slight increase |
| Receivables Days | ~53 days | ~52 days | Stable |
| Payables Days | ~73 days | ~57 days | Extended |

### Growth Metrics

| Metric | FY25 | FY24 | FY23 |
|--------|------|------|------|
| Revenue Growth | (0.4%) | +4.5% | +20.1% |
| Organic Growth | +1.0% | +1.3% | +13.6% |
| EPS Growth | +24.2% | +36.1% | +36.0% |
| FCF Growth | +12.1% | +14.7% | +17.9% |

---

## Fiscal Year 2026 Outlook

### Guidance Summary

| Metric | FY26 Guidance | FY25 Actual | Implied Change |
|--------|---------------|-------------|----------------|
| Sales Growth | 2.0% - 5.0% | (0.4%) | Improvement |
| Organic Growth | 1.5% - 4.5% | +1.0% | 50-350 bps |
| Adj Segment Margin | 26.3% - 26.7% | 26.1% | +20-60 bps |
| Adj EPS | $28.40 - $29.40 | $27.33 | +4-8% |
| Free Cash Flow | $3.0B - $3.4B | $3.34B | Flat to +2% |

### Key Assumptions

**Sales:**
- Aerospace: ~8% organic growth (high single digit)
- Industrial: ~1% organic growth (gradual recovery)
- Currency: +1.5% favorable
- Divestitures: (1.0%) impact

**Margins:**
- 35% incremental margins modeled
- Continued margin expansion through The Win Strategy
- Mix shift supportive (Aerospace growing faster)

**Other:**
- Tax rate: 22.5% (no discrete items assumed)
- CapEx: ~2.5% of sales ($515M)
- Restructuring: ~$70M (up from $56M)
- Share count: ~128.6M diluted shares

---

## Financial Strengths

1. **Exceptional Margin Performance:** Record adjusted segment operating margin of 26.1%, industry-leading levels
2. **Strong Cash Generation:** $3.78B operating cash flow (19% of sales), consistent double-digit growth
3. **Disciplined Capital Allocation:** Balanced approach to dividends, buybacks, debt reduction, and growth
4. **Robust Balance Sheet:** Healthy leverage (1.69x net debt/EBITDA), improving working capital
5. **Consistent Execution:** Margin expansion through cycle demonstrates structural improvements
6. **Portfolio Transformation:** Shift to longer-cycle/secular revenue mix reducing cyclicality

## Financial Risks

1. **Industrial Recovery Timing:** Weak industrial markets (Transportation, Off-Highway) could delay recovery
2. **Premium Valuation:** P/E ratio of 27.96x requires continued strong execution
3. **Working Capital Investment:** Expected to increase to support growth, impacting free cash flow
4. **Interest Rate Sensitivity:** Higher rates could impact customer spending decisions
5. **Tariff Management:** Ongoing tariff complexity requires continuous management
6. **Acquisition Integration:** Curtis Instruments integration and synergies need execution

---

## Conclusion

Parker-Hannifin delivered exceptional financial performance in FY25, achieving record margins and cash generation despite flat revenue growth. The company's ability to expand margins through a challenging industrial cycle demonstrates the power of The Win Strategy™ and operational excellence. Strong balance sheet metrics, disciplined capital allocation, and positive FY26 guidance support continued shareholder value creation. The premium valuation is justified by industry-leading margins and consistent execution, though requires continued strong performance to maintain.

---

**Related Documents:**
- [Market Analysis](2025_08_15_market_analysis.md)
- [Competitive Analysis](2025_08_15_competitive_analysis.md)
- [Investment Thesis](2025_08_15_investment_thesis.md)
- [Risk Assessment](2025_08_15_risk_assessment.md)
- [Valuation Analysis](2025_08_15_valuation_analysis.md)
